Summary
Updated Aug 31, 2026
Eugene Myron Holuka is Director of CITIUS ONCOLOGY, INC. (CTOR). 5 SEC Form 4 filings on record going back to 2024, most recently on 22 December 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Eugene Myron Holuka has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Eugene Myron Holuka go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Eugene Myron Holuka's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ILLUMINA, INC. - $79.85M of GRAL open-market activity in the last 12 months
- Darren M. Black - $77.56M of LFST open-market activity in the last 12 months
- Brian Guan-Chyun Liu - $74.81M of CGON open-market activity in the last 12 months
- Keith A. Meister - $74.03M of WGS open-market activity in the last 12 months
- Warren B. Kanders - $73.88M of CDRE open-market activity in the last 12 months
- Amirali Talasaz - $73.75M of GH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Eugene Myron Holuka?
Eugene Myron Holuka is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eugene Myron Holuka last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
Where can I see all of Eugene Myron Holuka's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Eugene Myron Holuka and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial